Associations between measures of vascular structure and function and systemic circulating blood markers in humans.
Examination of relationships between systemic markers and functional measures of arterial structure and function may assist in determining alternative indices of vascular regulation and designing and evaluating interventions to improve arterial structure and function. Twenty young healthy individuals, 20 older healthy men, and 26 individuals with coronary artery disease (CAD), comprising a spectrum of vascular health, participated. Systemic markers of vascular structure and function included: pro-collagen type I C-peptide (PIP) - marker of collagen synthesis, C-telopeptide of type I collagen (CTX) - marker of collagen degradation, endothelin-1 (ET-1) - vasoconstrictor, and interleukin-6 (IL-6) - inflammatory marker. Functional measures of arterial structure and function included carotid artery distensibility and brachial artery flow-mediated dilation (FMD). Moderate positive relationships were observed between carotid distensibility and CTX and PIP (r = 0.57, P < 0.0001 and r = 0.47, P < 0.0001). A negative correlation exists between ET-1 and FMD (r = -0.44, P = 0.0004); however, no relationship was observed between IL-6 and FMD (P = 0.25). Over a broad range of vascular health, relationships were observed between markers of type I collagen turnover and arterial stiffness and between a marker of vasoconstriction and endothelial function. These results indicate that regulatory links, between the indices examined, exist. Therefore, monitoring systemic markers rather than functional vascular measures, may provide sufficient information about vascular health and should be considered in the design and evaluation of vascular interventions.
Department of Kinesiology, McMaster University, Hamilton, Ontario, Canada.
Lisa M
LM
Cotie
Department of Kinesiology, McMaster University, Hamilton, Ontario, Canada.
Katharine D
KD
Currie
Department of Kinesiology, McMaster University, Hamilton, Ontario, Canada.
Greg M
GM
McGill
Department of Kinesiology, McMaster University, Hamilton, Ontario, Canada.
Austin J
AJ
Cameron
Department of Kinesiology, McMaster University, Hamilton, Ontario, Canada.
Alison S
AS
McFadden
Department of Kinesiology, McMaster University, Hamilton, Ontario, Canada.
Stuart M
SM
Phillips
Department of Kinesiology, McMaster University, Hamilton, Ontario, Canada macdonmj@mcmaster.ca.
Maureen J
MJ
MacDonald
Blood markers; vascular function; vascular structure
Circulation. 2004 Oct 12;110(15):2233-40
15466627
Circulation. 2004 Dec 7;110(23):3604-9
15569842
Eur J Heart Fail. 2008 Dec;10(12):1181-5
18849192
J Atheroscler Thromb. 2012;19(7):589-600
22498768
Hypertension. 2011 Mar;57(3):363-9
21263128
Eur Heart J. 2004 Oct;25(19):1754-60
15451155
J Lab Clin Med. 1989 May;113(5):604-11
2715682
Circulation. 2002 Sep 17;106(12):1439-41
12234944
Am J Physiol Heart Circ Physiol. 2005 Mar;288(3):H1016-21
15706038
Physiol Rep. 2016 Sep;4(18):
27670408
J Hum Hypertens. 2006 Nov;20(11):867-73
16598292
Nephrol Dial Transplant. 2011 Sep;26(9):2891-8
21562144
Hypertension. 1995 Jun;25(6):1135-43
7768553
Endocr J. 2011;58(5):349-54
21490407
Am J Hypertens. 2010 May;23(5):488-94
20134406
J Am Coll Cardiol. 2002 Jan 16;39(2):257-65
11788217
Arterioscler Thromb Vasc Biol. 2003 Feb 1;23(2):168-75
12588755
J Vasc Res. 1999 Mar-Apr;36(2):139-46
10213910
J Am Coll Cardiol. 2006 Nov 7;48(9):1846-50
17084260
J Am Coll Cardiol. 2009 Jan 27;53(4):323-30
19161880
Circulation. 2002 Aug 6;106(6):640-2
12163419
J Am Coll Cardiol. 1995 Nov 1;26(5):1235-41
7594037
J Hypertens. 2002 Jan;20(1):79-84
11791029
Hypertension. 1998 Sep;32(3):570-4
9740628
J Am Coll Cardiol. 1992 Oct;20(4):952-63
1527307
Int J Cardiol. 2009 May 1;134(1):52-8
18479768
J Cardiovasc Pharmacol. 2007 Dec;50(6):621-8
18091577
Hypertens Res. 2005 Dec;28(12):995-1001
16671339
Am J Hypertens. 2002 May;15(5):426-44
12022246
Front Genet. 2015 Mar 30;6:112
25926844